BROOKE WACKER: Open Payments
NPI 1033771563 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 21 payments from 14 companies in 2025. Trend: 2023 $89 · 2024 $173 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Alkermes, Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Corium, LLC | 1 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $23 |
| Bausch Health US, LLC | 1 | $22 |
Products named: COBENFY, CAPLYTA, REXULTI, LYBALVI, Azstarys, HETLIOZ, INVEGA SUSTENNA, ARISTADA.
Industry payments across CT — which companies pay providers there.
